Matched comparison of decellularized homografts and bovine jugular vein conduits for pulmonary valve replacement in congenital heart disease

Figures

• 

  Fig. 1. Kaplan–Meier curves for freedom from death, endocarditis, conduit-related catheter interventions and explantation for matched cohorts of decellularized pulmonary homografts (DPH) and bovine jugular vein conduits (BJV). p-values for pairwise comparisons are also given

• 

  Fig. 2. Kaplan–Meier curves for freedom from catheter valve implantation, stenosis, regurgitation, as well as freedom from combined degeneration and explantation. p-values for pairwise comparisons are also given

• 

  Fig. 3. Freedom from explantation and functional conduit status for matched decellularized pulmonary homograft (DPH) and bovine jugular vein (BJV) cohorts. We also analysed whether the yearly summarized fractions of intact DPHs during all the commonly observed years were larger than these fractions of BJVs. Detailed pairwise comparisons including p-values are provided in Table 2

• 

  Fig. 4. Kaplan–Meier curves for freedom from death, endocarditis, conduit-related catheter interventions and explantation for matched sub-cohorts of decellularized pulmonary homografts (DPH) and bovine jugular vein conduits (BJV), which were additionally limited to a comparison of grafts with 20–22 mm annulus diameter (± 2 mm). p-values for pairwise comparisons are also given

• 

  Fig. 5. Kaplan–Meier curves for freedom from catheter valve implantation, stenosis, regurgitation, as well as freedom from combined degeneration and explantation. For matched sub-cohorts of decellularized pulmonary homografts (DPH) and bovine jugular vein conduits (BJV), which were additionally limited to a comparison of grafts with 20–22 mm annulus diameter (± 2 mm). p-values for pairwise comparisons are also given